Table 2.
Between groups, within group, mean percentage changes of NTproBNP, left ventricle ejection fraction, C-reactive protein and Minnesota Living with Heart Failure Questionnaire score
| Parameter | Baseline | 3 months follow up | Percentage change from baseline | P (intergroup) | |
|---|---|---|---|---|---|
| LVEF (%) | Yoga | 33.37±2.76 | 36.77±2.99 | 10.46±7.62 | 0.001 |
| Control | 33.33±2.54 | 35.17±2.82 | 5.54±4.11 | ||
| NTproBNP (Pmol/l) | Yoga | 755.70±272.75 | 220.93±81.15 | 69.83±8.18 | <0.001 |
| Control | 679.17±225 | 406.83±154.86 | 39.36±13.51 | ||
| CRP (mg/L) | Yoga | 5.36±1.24 | 2.73±1.23 | 49.34±18.89 | 0.007 |
| Control | 5.39±2.02 | 3.45±1.74 | 35.81±22.43 | ||
| MLHFQ score | Yoga | 22.67±4.97 | 10.17±2.56 | 54.22±11.52 | <0.001 |
| Control | 21.03±3.49 | 14.07±3.45 | 33.21±10.25 |
LVEF=Left ventricle ejection fraction, CRP=C-reactive protein, MLHFQ=Minnesota Living with Heart Failure Questionnaire, NTproBNP=N-terminal B natriuretic peptide